Calbindin-D


Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
10 2020
Historique:
received: 20 02 2020
revised: 19 05 2020
accepted: 06 06 2020
pubmed: 15 7 2020
medline: 30 6 2021
entrez: 15 7 2020
Statut: ppublish

Résumé

Certain neuronal populations, including basal forebrain cholinergic neurons (BFCN) and noradrenergic neurons of the locus coeruleus (LC), are selectively vulnerable to pathology and loss early in the course of aging and Alzheimer's disease (AD). Human BFCN show substantial loss of the calcium-binding protein (CBP), calbindin-D

Identifiants

pubmed: 32663717
pii: S0197-4580(20)30197-4
doi: 10.1016/j.neurobiolaging.2020.06.006
pmc: PMC7483964
mid: NIHMS1604035
pii:
doi:

Substances chimiques

Calbindin 1 0
Calbindin 2 0
Parvalbumins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-249

Subventions

Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG014706
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG027141
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Behav Brain Res. 2011 Aug 10;221(2):555-63
pubmed: 21145918
Brain Pathol. 2016 May;26(3):371-86
pubmed: 26193084
J Neurol Sci. 1981 Mar;49(3):419-28
pubmed: 7217992
Neuroreport. 1997 Jul 7;8(9-10):2209-13
pubmed: 9243613
Brain. 2015 Jun;138(Pt 6):1722-37
pubmed: 25732182
Neurobiol Aging. 2019 Feb;74:101-111
pubmed: 30447418
J Neurosci. 1981 Aug;1(8):887-900
pubmed: 7346593
Neuropathology. 2006 Dec;26(6):528-32
pubmed: 17203588
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9
pubmed: 22002422
J Neurosci. 1988 May;8(5):1776-88
pubmed: 3367220
Curr Neuropharmacol. 2008 Sep;6(3):235-53
pubmed: 19506723
Annu Rev Nutr. 1989;9:347-76
pubmed: 2548544
Neuroscience. 1983;8(1):3-32
pubmed: 6132348
J Neuropathol Exp Neurol. 2018 Feb 1;77(2):149-161
pubmed: 29304218
J Psychopharmacol. 2013 Aug;27(8):659-93
pubmed: 23761387
Nat Rev Neurosci. 2009 Mar;10(3):211-23
pubmed: 19190638
J Comp Neurol. 1983 Feb 20;214(2):170-97
pubmed: 6841683
Acta Neuropathol. 2011 Nov;122(5):565-76
pubmed: 21874328
Alzheimers Dement. 2017 Mar;13(3):236-246
pubmed: 27513978
Adv Exp Med Biol. 2012;740:461-82
pubmed: 22453954
Ann Neurol. 2004 Jun;55(6):815-28
pubmed: 15174015
Acta Neuropathol. 2011 Feb;121(2):171-81
pubmed: 21170538
J Chem Neuroanat. 2013 Sep;52:69-79
pubmed: 23796985
Neural Plast. 2017;2017:7829507
pubmed: 29038736
J Histochem Cytochem. 1981 Apr;29(4):577-80
pubmed: 6166661
J Comp Neurol. 2003 Jul 21;462(2):153-67
pubmed: 12794740
Curr Neuropharmacol. 2008 Sep;6(3):254-85
pubmed: 19506724
J Neuropathol Exp Neurol. 1998 Jan;57(1):63-75
pubmed: 9600198
J Neuropathol Exp Neurol. 2008 Apr;67(4):309-18
pubmed: 18379437
J Alzheimers Dis Rep. 2017 Nov 14;1(1):159-167
pubmed: 30480235
Neurobiol Aging. 2007 Mar;28(3):327-35
pubmed: 16574280
Neurobiol Aging. 2003 Jan-Feb;24(1):1-23
pubmed: 12493547
Neurosci Lett. 1983 Aug 19;39(1):95-100
pubmed: 6633940
Neurobiol Aging. 2015 Dec;36(12):3163-3170
pubmed: 26417681
Alzheimer Dis Assoc Disord. 1993 Summer;7(2):69-79
pubmed: 8347330
J Comp Neurol. 2003 Jan 6;455(2):249-59
pubmed: 12454989
Arch Neurol. 2003 Mar;60(3):337-41
pubmed: 12633144
Cell. 2017 Aug 24;170(5):1000-1012.e19
pubmed: 28823555
J Histochem Cytochem. 1986 Nov;34(11):1449-57
pubmed: 2430010
Neuropathol Appl Neurobiol. 2017 Aug;43(5):393-408
pubmed: 28117917
Annu Rev Neurosci. 2007;30:123-52
pubmed: 17417939
Neuroscience. 1993 May;54(2):461-76
pubmed: 8336832
J Neuropathol Exp Neurol. 2003 Jun;62(6):605-16
pubmed: 12834105

Auteurs

Sydney Lamerand (S)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Ryan Shahidehpour (R)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Ivan Ayala (I)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Tamar Gefen (T)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

M-Marsel Mesulam (MM)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Eileen Bigio (E)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Changiz Geula (C)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: c-geula@northwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH